In the present study, we demonstrated for the first time that enhanced local intestinal CCL20 expression in IBD, as previously described14, is accompanied by systemically upregulated levels of this crucial gut-derived Th17 cell chemoattractant not only in patients with Crohn’s disease16 but also in those with ulcerative colitis. The gene discussed is CCL20; the disease is inflammatory bowel disease.